Currently Examining Financial Impact Of Rapid Safety Communication Regarding Tavneos (Generic Name Avacopan)
21/05/2026 06:12
Kissei Pharmaceutical Co Ltd 4547.T: KISSEI PHARMACEUTICAL CO - CURRENTLY EXAMINING FINANCIAL IMPACT OF RAPID SAFETY COMMUNICATION REGARDING TAVNEOS (GENERIC NAME: AVACOPAN) Source text: ID:nTSqu84b11 Further company coverage: 4547.T
Recent news on Kissei Pharmaceutical Co
See all newsAmgen up after EMA recommends revoking marketing authorization for rare-disease drug
Submission Of New Drug Application For Acute Myeloid Leukemia Treatment "Olutasidenib" In Japan
Currently Examining Financial Impact Of Rapid Safety Communication Regarding Tavneos (Generic Name Avacopan)
Advisory: Incorrectly tagged Kissei alert withdrawn
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports (updated)